Sage Journals: Discover world-class research

Retricted access

Research article

First published 2025-8

An ALK Immunohistochemical Pitfall: ALK -Positive Histiocytosis Versus Angiomatoid Fibrous Histiocytoma

Justin Chang, Anna C. Greenwood, Chelsea Kidd [...]

International Journal of Surgical Pathology

Retricted access

Research article

First published 2026-2

ALK Inhibition Prolongs Survival in a Mouse Model of ALK -Positive Anaplastic Thyroid Cancer

Yara Maria Machlah, Tim Brandenburg, Georg Sebastian Hönes [...]

Thyroid®

Retricted access

Review article

First published 2012-6

Targeted therapy for NSCLC: ALK inhibition

Rachel Pearson, Jill M Kolesar

Journal of Oncology Pharmacy Practice

Retricted access

Case report

First published 2021-8

Local ALK-Positive Histiocytosis With Unusual Morphology and Novel TRIM33-ALK Gene Fusion

Tien Anh N. Tran, Kenneth Tou En Chang, Chik Hong Kuick [...]

International Journal of Surgical Pathology

Retricted access

Research article

First published 2013-09

Fishing for ALK with immunohistochemistry may predict response to crizotinib

Mario Bavieri, Marcello Tiseo, Sylvie Lantuejoul [...]

Tumori Journal

Free access

Review article

First published 2015-10

The efficacy of ceritinib in patients with ALK -positive non-small cell lung cancer

John Kaczmar, Ranee Mehra

Therapeutic Advances in Respiratory Disease

Retricted access

Research article

First published 2018-3

Alk Immunohistochemistry is Highly Sensitive and Specific for the Detection of Alk Translocated Lung Adenocarcinomas: Lessons from An Audit of Lung Cancer Molecular Testing

YC Kheng, K Walsh, L Williams [...]

Journal of the Royal College of Physicians of Edinburgh

Open access

Review article

First published 2018

Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties,efficacy,safety and place in therapy

Tiziana Vavalà, Silvia Novello

Therapeutic Advances in Medical Oncology

Open access

Case report

First published 2020

Acquired multiple mutations ALK I1171N,L1196M and G1202R mediate lorlatinib resistance in EML4-ALK-rearranged malignant pleural mesothelioma: a case report

Jia Hu, Baoshi Zhang, Fangfang Yao [...]

Therapeutic Advances in Respiratory Disease

Free access

Research article

First published 2011-2

Comparison of 2 Cell-Based Phosphoprotein Assays to Support Screening and Development of an ALK Inhibitor

Allison E. Drew, Samer Al-Assaad, Violeta Yu [...]

Journal of Biomolecular Screening

Search results